Tan Jie
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease. (NCT06659653) | Tan Jie | 2024-05-24 |
Track Tan Jie automatically
Every clearance here is in the API, with alerts when new ones post.